Transposagen Biopharmaceuticals, Inc.
Engineered transgenic animals and derived antibodies using transposon-based genetic modification technology
- Sector
- Biotech
- Headquarters
- LEXINGTON, KY
- Founded
- 2011
- Latest Form D
- $355K, Jul 2012
- Total capital
- $1.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.1M
- 2 Form D · last Jul 2012
- 171 months since last filing
- Federal contracts
- $56K
- 3 awards · Health and Human S
- Rank in Biotech#352 of 4373
- Granted patents
- 0
- 20 pending
Capital timeline
Latest events
- Federal contractHealth and Human S · Igf::ot::igf Gene Edited 'knockout' Rat$22K
- Federal contractHealth and Human S · Igf::ot::igf Transposagen Biopharmaceuticals INC:1188443 [14-000683]$14K
- Federal contractHealth and Human S · Transposagen Biopharmaceuticals INC:1188443 [12-005765]$20K
- Private capital raisedForm D · SEC · 2nd filing$355K
- Private capital raisedForm D · SEC · 1st filing$725K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Eric M. OstertagExecutive Officer, DirectorNamed in SEC Form D filings
- Joseph M. RuizExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 20- PendingGenetically Modified Rat Models For Severe Combined Immunodeficiency (scid)USPTOApplication 15070275
- PendingGenetically Modified Rat Models For Drug MetabolismUSPTOApplication 15040254
- PendingGenetically Modified Rat Models For PainUSPTOApplication 14979760
Show all 20 patent records
- Genetically Modified Rat Models For Severe Combined Immunodeficiency (scid)Oct 20, 2016 · Application 15070275Pending
- Genetically Modified Rat Models For Drug MetabolismJun 23, 2016 · Application 15040254Pending
- Genetically Modified Rat Models For PainJun 23, 2016 · Application 14979760Pending
- Genetically Modified Rat Models For PharmacokineticsJun 23, 2016 · Application 14979754Pending
- Genetically Modified Rat Models For PainFeb 19, 2015 · Application 14502775Pending
- Genetically Modified Rat Models For PharmacokineticsFeb 19, 2015 · Application 14501484Pending
- Genetically Modified Rat Models for Obesity and DiabetesFeb 6, 2014 · Application 14017762Pending
- Trp Inhibitors And Uses ThereofApplication PCTUS2010046151Pending
- Genetically Modified Rat Models For Drug MetabolismApplication PCTUS2010044545Pending
- Genetically Modified Rat Models For PharamacokineticsApplication PCTUS2010043817Pending
- Genetically Modified Rat Models For Cytokine-cytokine Signaling PathwaysApplication PCTUS2010043043Pending
- Genetically Modified Rat Models For Severe Combined Immunodeficiency (scid)Application PCTUS2010040768Pending
- Genetically Modified Rat Models For CancerApplication PCTUS2010032222Pending
- Hyperactive Piggybac TransposasesApplication PCTUS2010025380Pending
- Reproducible Method For Testis-mediated Genetic Modification (tgm) And Sperm-mediated Genetic Modification (sgm)Application PCTUS2014030546Pending
- Site-specific Enzymes And Methods Of UseApplication PCTUS2013070636Pending
- Method Of Treating PainApplication PCTUS2012069753Pending
- Methods For Transgenesis Of Spermatogonial Stem Cells (sscs) And Organisms Using Transposon VectorsApplication PCTUS2012038461Pending
- Genetically Modified Rat Models For Obesity And DiabetesApplication PCTUS2012029736Pending
- Genetically Modified Rat Models For PainApplication PCTUS2010046144Pending
Related companies, and why
- Radiant Genomics, Inc.Similar federal contract value in Biotech · $63K in contracts
- LEADSCOPE, INC.Similar federal contract value in Biotech · $62K in contracts
- Emmaus Life Sciences, Inc.Similar federal contract value in Biotech · $60K in contracts
- Mitochon Pharmaceuticals, Inc.Similar federal contract value in Biotech · $50K in contracts
- Oralome IncSimilar federal contract value in Biotech · $50K in contracts
- AlleviSimilar federal contract value in Biotech · $49K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .